Literature DB >> 1362763

An automated flow cytometric micronucleus assay for human lymphocytes.

G A Schreiber1, W Beisker, H Braselmann, M Bauchinger, K W Bögl, M Nüsse.   

Abstract

A new flow cytometric method is presented for scoring micronuclei (MN) in human lymphocytes after in vitro gamma-irradiation. Fifty to fifty-five hours after PHA-stimulation, the frequency of micronuclei per nucleus and the fraction of cells in the second cell cycle were measured using flow cytometry. All data were automatically analysed using our DAS-software package. Eight individual linear-quadratic dose response curves derived from five donors revealed inter- and intra-individual variabilities of all curve parameters. Since also an age dependence was found for spontaneous MN-frequencies and for the linear curve parameter, a combined linear-quadratic age-dose-effect model was used to fit the data. The 90% prediction intervals show that a reliable individual dose estimation for donors aged between 23 and 54 years cannot be achieved for exposures below 1 Gy.

Entities:  

Mesh:

Year:  1992        PMID: 1362763     DOI: 10.1080/09553009214552651

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  3 in total

Review 1.  Radiation signature on exposed cells: Relevance in dose estimation.

Authors:  Venkatachalam Perumal; Tamizh Selvan Gnana Sekaran; Venkateswarlu Raavi; Safa Abdul Syed Basheerudeen; Karthik Kanagaraj; Amith Roy Chowdhury; Solomon Fd Paul
Journal:  World J Radiol       Date:  2015-09-28

2.  In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity.

Authors:  Steven M Bryce; Jeffrey C Bemis; Svetlana L Avlasevich; Stephen D Dertinger
Journal:  Mutat Res       Date:  2007-03-19       Impact factor: 2.433

3.  The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cells.

Authors:  Carmela Fimognari; Michael Nüsse; Renato Iori; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.